Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States DONESTA® for the treatment of vasomotor symptoms of menopause, is expected to target...

Mithra Announces New Positive Preclinical Data from CSF-1R Inhibitor Program Mithra Announces New Positive Preclinical Data from CSF-1R Inhibitor Program CSF-1R inhibitors show promising anti-tumor activityLead compound shows synergy with PD1 cancer immune checkpoint...